Compare GNLX & ACR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GNLX | ACR |
|---|---|---|
| Founded | 2001 | 2005 |
| Country | United States | United States |
| Employees | N/A | 4 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 133.0M | 146.1M |
| IPO Year | 2022 | N/A |
| Metric | GNLX | ACR |
|---|---|---|
| Price | $3.00 | $17.36 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 1 |
| Target Price | $17.25 | ★ $24.50 |
| AVG Volume (30 Days) | ★ 190.8K | 46.6K |
| Earning Date | 05-12-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 9.47 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $19.59 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.29 | $15.61 |
| 52 Week High | $8.54 | $24.61 |
| Indicator | GNLX | ACR |
|---|---|---|
| Relative Strength Index (RSI) | 54.95 | 42.66 |
| Support Level | $2.62 | $15.61 |
| Resistance Level | $3.21 | $18.74 |
| Average True Range (ATR) | 0.16 | 0.61 |
| MACD | 0.01 | 0.07 |
| Stochastic Oscillator | 58.97 | 38.10 |
Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.
ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding, and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralized debt obligations, and private equity investments mainly issued by financial institutions.